Monocyclic .beta.-lactams as intermediates for the...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260/335.5

C07D 205/08 (2006.01)

Patent

CA 1110252

ABSTRACT OF THE DISCLOSURE The present invention provides for the stereoselective total synthesis of certain novel substituted .DELTA. 2,3-1,4- morpholine-2-carboxylic acids possessing a fused .beta.-lactam ring in the 1,6-position and carrying a substituent cis to carbon 5 in the 7-position of the fused ring system represented by the general formula Image wherein Q is hydrogen, alkyl, aralkyl or -CH2COOZ where Z is hydrogen or the residue of an ester group and X is azido, amino or acylamino. When X is acylamino, these acids (and their pharmaceutically acceptable salts and physiologically hydrolyzed esters) are potent antibacterial agents. This divisional is directed to enol intermediate products used in the above preparation, and having the formula Image ?? wherein R" is an easily cleavable ester selected from the group consisting of benzhydryl, benzyl, p-nitrobenzyl, p-methoxybenzyl, trichloroethyl, trimethylsilyl, phenacyl, acetonyl, (lower)alkyl, triphenylmethyl, methoxymethyl, indanyl, phthalidyl, pivaloyl- oxymethyl and acetoxymethyl.

364191

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Monocyclic .beta.-lactams as intermediates for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monocyclic .beta.-lactams as intermediates for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monocyclic .beta.-lactams as intermediates for the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1100355

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.